Hodges Capital Management Inc. Bausch & Lomb Corp Transaction History

Hodges Capital Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$14.87 - $17.56 $2.04 Million - $2.41 Million	-137,332 Reduced 42.62%	184,900 $3.16 Million
Q3 2023 Nov 14, 2023	SELL	$16.8 - $20.99 $3.46 Million - $4.32 Million	-205,759 Reduced 38.97%	322,232 $5.46 Million
Q2 2023 Aug 04, 2023	BUY	$16.03 - $20.07 $3.87 Million - $4.84 Million	241,152 Added 84.07%	527,991 $15.1 Million
Q1 2023 May 15, 2023	SELL	$15.67 - $18.91 $2.91 Million - $3.51 Million	-185,870 Reduced 39.32%	286,839 $8.23 Million
Q4 2022 Feb 03, 2023	BUY	$13.5 - $17.14 $4.29 Million - $5.44 Million	317,632 Added 204.82%	472,709 $7.33 Million
Q3 2022 Oct 21, 2022	BUY	$14.23 - $17.76 $2.21 Million - $2.75 Million	155,077 New	155,077 $2.38 Million

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.3B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hodges Capital Management Inc. with notifications on news.